Captrust Financial Advisors »

Transcode Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.3k 16k 0.57
2024-06-30 $11k 11k 1.01
2023-12-31 $8.2k 50k 0.16

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard Value Etf (VTV)
Microsoft Corp Stock (MSFT)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Vanguard Mega Cap Growth Etf Etf (MGK)
Vanguard Growth Etf Etf (VUG)
Vanguard Small-cap Etf Etf (VB)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Core Msci Emerging Market Etf Etf (IEMG)

View all positions for Captrust Financial Advisors

Top funds holding Transcode Therapeutics

Geode Capital Management
Sheets Smith Wealth Management
Jane Street
Private Capital Management
Captrust Financial Advisors
Two Sigma Securities
Morgan Stanley
Tower Research Capital
Bank of America Corporation

View all funds holding Transcode Therapeutics